Aspire Private Capital, LLC Wave Life Sciences Ltd. Transaction History
Aspire Private Capital, LLC
- $385 Million
- Q2 2024
A detailed history of Aspire Private Capital, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Aspire Private Capital, LLC holds 150 shares of WVE stock, worth $1,243. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150Holding current value
$1,243% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding WVE
# of Institutions
146Shares Held
93.1MCall Options Held
33KPut Options Held
57.2K-
Ra Capital Management, L.P. Boston, MA18.2MShares$151 Million1.37% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx7.67MShares$63.6 Million0.75% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$55.9 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$51.1 Million35.47% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.36MShares$44.4 Million0.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $720M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...